Maqsood R, Rehman A, Awan F, Rashid H, Gill S, Jabeen C
J Adv Vet Anim Res. 2025; 11(4):967-978.
PMID: 40013293
PMC: 11855439.
DOI: 10.5455/javar.2024.k847.
Wang S, Gu R, Ren P, Chen Y, Wu D, Li L
Front Public Health. 2025; 12:1515867.
PMID: 39882120
PMC: 11774867.
DOI: 10.3389/fpubh.2024.1515867.
Boucaid A, Zegmout A, Bhairis M, Amraoui M, Laaraje A, Hassane Kabiri E
Cureus. 2025; 16(12):e75740.
PMID: 39816277
PMC: 11732615.
DOI: 10.7759/cureus.75740.
Alsehali A, Alrajih H, Al-Jahdali H, Al-Safi E, Layqah L, Baharoon S
J Epidemiol Glob Health. 2024; 14(4):1591-1601.
PMID: 39470976
PMC: 11652542.
DOI: 10.1007/s44197-024-00311-8.
Yoon J, Kim T, Kim J, Kim H, Lee E, Jung S
PLoS One. 2024; 19(9):e0309902.
PMID: 39325726
PMC: 11426458.
DOI: 10.1371/journal.pone.0309902.
Malnutrition and unsuccessful tuberculosis treatment among people with multi-drug resistant tuberculosis in Uganda: A retrospective analysis.
Engoru S, Bajunirwe F, Izudi J
J Clin Tuberc Other Mycobact Dis. 2024; 37:100477.
PMID: 39224115
PMC: 11367710.
DOI: 10.1016/j.jctube.2024.100477.
Tuberculosis survivors and the risk of cardiovascular disease: analysis using a nationwide survey in Korea.
Yang J, Kim S, Sim J, Gu S, Seok J, Bae D
Front Cardiovasc Med. 2024; 11:1364337.
PMID: 39185138
PMC: 11341360.
DOI: 10.3389/fcvm.2024.1364337.
Timing and predictors of death during treatment in patients with multidrug/rifampin-resistant tuberculosis in South Korea.
Son E, Choi H, Mok J, Kang Y, Jeong D, Jeon D
Korean J Intern Med. 2024; 39(4):640-649.
PMID: 38910510
PMC: 11236803.
DOI: 10.3904/kjim.2024.029.
Factors associated with unfavorable treatment outcomes among multidrug-resistant tuberculosis patients, Sierra Leone: a cross-sectional secondary data analysis.
Koroma J, Elduma A, Sesay U, Gebru G
BMC Infect Dis. 2024; 24(1):579.
PMID: 38862873
PMC: 11167780.
DOI: 10.1186/s12879-024-09370-5.
Treatment success rate and associated factors among drug susceptible tuberculosis individuals in St. Kizito Hospital, Matany, Napak district, Karamoja region. A retrospective study.
Opito R, Kwenya K, Ssentongo S, Kizito M, Alwedo S, Bakashaba B
PLoS One. 2024; 19(5):e0300916.
PMID: 38743721
PMC: 11093355.
DOI: 10.1371/journal.pone.0300916.
High all-cause mortality and increasing proportion of older adults with tuberculosis in Texas, 2008-2020.
Medrano B, Lee M, Gemeinhardt G, Yamba L, Restrepo B
Epidemiol Infect. 2024; 152:e82.
PMID: 38736419
PMC: 11131009.
DOI: 10.1017/S0950268824000669.
Subclinical tuberculosis: a meta-analysis of prevalence and scoping review of definitions, prevalence and clinical characteristics.
Teo A, MacLean E, Fox G
Eur Respir Rev. 2024; 33(172).
PMID: 38719737
PMC: 11078153.
DOI: 10.1183/16000617.0208-2023.
A Study on Risk Factors for Readmission of Elderly Patients with Pulmonary Tuberculosis Within One Month Using Propensity Score Matching Method.
Feng Y, Guo J, Luo S, Zhang Z, Liu Z
Infect Drug Resist. 2024; 17:1625-1632.
PMID: 38699076
PMC: 11063109.
DOI: 10.2147/IDR.S459260.
The Impact of Immune System Aging on Infectious Diseases.
Quiros-Roldan E, Sottini A, Natali P, Imberti L
Microorganisms. 2024; 12(4).
PMID: 38674719
PMC: 11051847.
DOI: 10.3390/microorganisms12040775.
Global, regional, and national age-specific progress towards the 2020 milestones of the WHO End TB Strategy: a systematic analysis for the Global Burden of Disease Study 2021.
Lancet Infect Dis. 2024; 24(7):698-725.
PMID: 38518787
PMC: 11187709.
DOI: 10.1016/S1473-3099(24)00007-0.
Comparison of the yield of two tuberculosis screening approaches among household contacts in a community setting of Silti Zone, Central Ethiopia: a prospective cohort study.
Wolde H, Zerihun B, Sinshaw W, Yewhalaw D, Abebe G
BMC Pulm Med. 2024; 24(1):135.
PMID: 38491509
PMC: 10943764.
DOI: 10.1186/s12890-024-02950-w.
Possible Mechanisms of Lymphopenia in Severe Tuberculosis.
Li F, Chen D, Zeng Q, Du Y
Microorganisms. 2023; 11(11).
PMID: 38004652
PMC: 10672989.
DOI: 10.3390/microorganisms11112640.
Risk of loss to follow-up among tuberculosis patients in South Korea: whom should we focus on?.
Kim H, Min J, Ko Y, Oh J, Jeong Y, Lee E
Front Public Health. 2023; 11:1247772.
PMID: 37927864
PMC: 10622659.
DOI: 10.3389/fpubh.2023.1247772.
Tuberculosis in older adults: challenges and best practices in the Western Pacific Region.
Teo A, Morishita F, Islam T, Viney K, Ong C, Kato S
Lancet Reg Health West Pac. 2023; 36:100770.
PMID: 37547037
PMC: 10398605.
DOI: 10.1016/j.lanwpc.2023.100770.
Factors associated with adverse drug reactions or death in very elderly hospitalized patients with pulmonary tuberculosis.
Yagi M, Shindo Y, Mutoh Y, Sano M, Sakakibara T, Kobayashi H
Sci Rep. 2023; 13(1):6826.
PMID: 37100850
PMC: 10133295.
DOI: 10.1038/s41598-023-33967-6.